• レポートコード:QYR2104Z3066 • 出版社/出版日:QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態:英文、PDF、92ページ • 納品方法:Eメール(納期:3日) • 産業分類:医療 |
Single User | ¥546,000 (USD3,900) | ▷ お問い合わせ |
Multi User/Five User | ¥819,000 (USD5,850) | ▷ お問い合わせ |
Enterprise License(同一法人内共有可) | ¥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、In Situハイブリダイゼーションのグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(蛍光in situハイブリダイゼーション(FISH)、発色性in situハイブリダイゼーション)、用途別市場規模(がん診断、免疫、神経科、細胞、感染症)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。 ・市場概要 ・In Situハイブリダイゼーションの市場動向 ・企業の競争状況、市場シェア ・In Situハイブリダイゼーションの種類別市場規模(蛍光in situハイブリダイゼーション(FISH)、発色性in situハイブリダイゼーション) ・In Situハイブリダイゼーションの用途別市場規模(がん診断、免疫、神経科、細胞、感染症) ・In Situハイブリダイゼーションの北米市場規模2016-2027(アメリカ、カナダ) ・In Situハイブリダイゼーションのヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等) ・In Situハイブリダイゼーションのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等) ・In Situハイブリダイゼーションの中南米市場規模2016-2027(メキシコ、ブラジル) ・In Situハイブリダイゼーションの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等) ・主要企業情報(Abbott Laboratories、Roche、Thermo Fisher Scientific、Merck、Agilent Technologies、Perkin Elmer、Danaher、Exiqon、Biogenex Laboratories、Advanced Cell Diagnostics、Bio Sb) ・結論 |
In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acids strand to localize a specific DNA or RNA sequence in a portion or section of tissue (in situ), or, if the tissue is small enough, in the entire tissue, in cells, and in circulating tumor cells (CTCs). This is distinct from immunohistochemistry, which usually localizes proteins in tissue sections.
North America is expected to account for the largest share of the market in 2018. This can be attributed to growing clinical and research in cancer by biotechnology and pharmaceutical companies, government initiatives, increasing prevalence and diagnosis of cancer in the U.S. and Canada, and increasing adoption of companion diagnostics. Increased adoption of companion diagnostics is attributed to the development and launch of newer therapeutic agents. However, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. This can be attributed to the growing presence of international players in China and India, increasing cancer prevalence and diagnosis, and increased healthcare expenditure across the Asia-Pacific region are drivers for the in situ hybridization market in this region.
Market Analysis and Insights: Global In situ Hybridization Market
The global In situ Hybridization market size is projected to reach US$ 682.5 million by 2026, from US$ 542.8 million in 2019, at a CAGR of 3.3% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global In situ Hybridization market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global In situ Hybridization market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global In situ Hybridization market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global In situ Hybridization market.
Global In situ Hybridization Scope and Market Size
In situ Hybridization market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global In situ Hybridization market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Fluorescence In Situ Hybridization (FISH)
Chromogenic In Situ Hybridization
Segment by Application
Cancer Diagnosis
Immunology
Neuroscience
Cytology
Infectious Diseases
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboratories
Roche
Thermo Fisher Scientific
Merck
Agilent Technologies
Perkin Elmer
Danaher
Exiqon
Biogenex Laboratories
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In situ Hybridization Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Fluorescence In Situ Hybridization (FISH)
1.2.3 Chromogenic In Situ Hybridization
1.3 Market by Application
1.3.1 Global In situ Hybridization Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer Diagnosis
1.3.3 Immunology
1.3.4 Neuroscience
1.3.5 Cytology
1.3.6 Infectious Diseases
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global In situ Hybridization Market Perspective (2016-2027)
2.2 In situ Hybridization Growth Trends by Regions
2.2.1 In situ Hybridization Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 In situ Hybridization Historic Market Share by Regions (2016-2021)
2.2.3 In situ Hybridization Forecasted Market Size by Regions (2022-2027)
2.3 In situ Hybridization Industry Dynamic
2.3.1 In situ Hybridization Market Trends
2.3.2 In situ Hybridization Market Drivers
2.3.3 In situ Hybridization Market Challenges
2.3.4 In situ Hybridization Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In situ Hybridization Players by Revenue
3.1.1 Global Top In situ Hybridization Players by Revenue (2016-2021)
3.1.2 Global In situ Hybridization Revenue Market Share by Players (2016-2021)
3.2 Global In situ Hybridization Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by In situ Hybridization Revenue
3.4 Global In situ Hybridization Market Concentration Ratio
3.4.1 Global In situ Hybridization Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In situ Hybridization Revenue in 2020
3.5 In situ Hybridization Key Players Head office and Area Served
3.6 Key Players In situ Hybridization Product Solution and Service
3.7 Date of Enter into In situ Hybridization Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In situ Hybridization Breakdown Data by Type
4.1 Global In situ Hybridization Historic Market Size by Type (2016-2021)
4.2 Global In situ Hybridization Forecasted Market Size by Type (2022-2027)
5 In situ Hybridization Breakdown Data by Application
5.1 Global In situ Hybridization Historic Market Size by Application (2016-2021)
5.2 Global In situ Hybridization Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America In situ Hybridization Market Size (2016-2027)
6.2 North America In situ Hybridization Market Size by Type
6.2.1 North America In situ Hybridization Market Size by Type (2016-2021)
6.2.2 North America In situ Hybridization Market Size by Type (2022-2027)
6.2.3 North America In situ Hybridization Market Size by Type (2016-2027)
6.3 North America In situ Hybridization Market Size by Application
6.3.1 North America In situ Hybridization Market Size by Application (2016-2021)
6.3.2 North America In situ Hybridization Market Size by Application (2022-2027)
6.3.3 North America In situ Hybridization Market Size by Application (2016-2027)
6.4 North America In situ Hybridization Market Size by Country
6.4.1 North America In situ Hybridization Market Size by Country (2016-2021)
6.4.2 North America In situ Hybridization Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe In situ Hybridization Market Size (2016-2027)
7.2 Europe In situ Hybridization Market Size by Type
7.2.1 Europe In situ Hybridization Market Size by Type (2016-2021)
7.2.2 Europe In situ Hybridization Market Size by Type (2022-2027)
7.2.3 Europe In situ Hybridization Market Size by Type (2016-2027)
7.3 Europe In situ Hybridization Market Size by Application
7.3.1 Europe In situ Hybridization Market Size by Application (2016-2021)
7.3.2 Europe In situ Hybridization Market Size by Application (2022-2027)
7.3.3 Europe In situ Hybridization Market Size by Application (2016-2027)
7.4 Europe In situ Hybridization Market Size by Country
7.4.1 Europe In situ Hybridization Market Size by Country (2016-2021)
7.4.2 Europe In situ Hybridization Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific In situ Hybridization Market Size (2016-2027)
8.2 Asia-Pacific In situ Hybridization Market Size by Type
8.2.1 Asia-Pacific In situ Hybridization Market Size by Type (2016-2021)
8.2.2 Asia-Pacific In situ Hybridization Market Size by Type (2022-2027)
8.2.3 Asia-Pacific In situ Hybridization Market Size by Type (2016-2027)
8.3 Asia-Pacific In situ Hybridization Market Size by Application
8.3.1 Asia-Pacific In situ Hybridization Market Size by Application (2016-2021)
8.3.2 Asia-Pacific In situ Hybridization Market Size by Application (2022-2027)
8.3.3 Asia-Pacific In situ Hybridization Market Size by Application (2016-2027)
8.4 Asia-Pacific In situ Hybridization Market Size by Region
8.4.1 Asia-Pacific In situ Hybridization Market Size by Region (2016-2021)
8.4.2 Asia-Pacific In situ Hybridization Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America In situ Hybridization Market Size (2016-2027)
9.2 Latin America In situ Hybridization Market Size by Type
9.2.1 Latin America In situ Hybridization Market Size by Type (2016-2021)
9.2.2 Latin America In situ Hybridization Market Size by Type (2022-2027)
9.2.3 Latin America In situ Hybridization Market Size by Type (2016-2027)
9.3 Latin America In situ Hybridization Market Size by Application
9.3.1 Latin America In situ Hybridization Market Size by Application (2016-2021)
9.3.2 Latin America In situ Hybridization Market Size by Application (2022-2027)
9.3.3 Latin America In situ Hybridization Market Size by Application (2016-2027)
9.4 Latin America In situ Hybridization Market Size by Country
9.4.1 Latin America In situ Hybridization Market Size by Country (2016-2021)
9.4.2 Latin America In situ Hybridization Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In situ Hybridization Market Size (2016-2027)
10.2 Middle East & Africa In situ Hybridization Market Size by Type
10.2.1 Middle East & Africa In situ Hybridization Market Size by Type (2016-2021)
10.2.2 Middle East & Africa In situ Hybridization Market Size by Type (2022-2027)
10.2.3 Middle East & Africa In situ Hybridization Market Size by Type (2016-2027)
10.3 Middle East & Africa In situ Hybridization Market Size by Application
10.3.1 Middle East & Africa In situ Hybridization Market Size by Application (2016-2021)
10.3.2 Middle East & Africa In situ Hybridization Market Size by Application (2022-2027)
10.3.3 Middle East & Africa In situ Hybridization Market Size by Application (2016-2027)
10.4 Middle East & Africa In situ Hybridization Market Size by Country
10.4.1 Middle East & Africa In situ Hybridization Market Size by Country (2016-2021)
10.4.2 Middle East & Africa In situ Hybridization Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories In situ Hybridization Introduction
11.1.4 Abbott Laboratories Revenue in In situ Hybridization Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche In situ Hybridization Introduction
11.2.4 Roche Revenue in In situ Hybridization Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific In situ Hybridization Introduction
11.3.4 Thermo Fisher Scientific Revenue in In situ Hybridization Business (2016-2021)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck In situ Hybridization Introduction
11.4.4 Merck Revenue in In situ Hybridization Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Agilent Technologies
11.5.1 Agilent Technologies Company Details
11.5.2 Agilent Technologies Business Overview
11.5.3 Agilent Technologies In situ Hybridization Introduction
11.5.4 Agilent Technologies Revenue in In situ Hybridization Business (2016-2021)
11.5.5 Agilent Technologies Recent Development
11.6 Perkin Elmer
11.6.1 Perkin Elmer Company Details
11.6.2 Perkin Elmer Business Overview
11.6.3 Perkin Elmer In situ Hybridization Introduction
11.6.4 Perkin Elmer Revenue in In situ Hybridization Business (2016-2021)
11.6.5 Perkin Elmer Recent Development
11.7 Danaher
11.7.1 Danaher Company Details
11.7.2 Danaher Business Overview
11.7.3 Danaher In situ Hybridization Introduction
11.7.4 Danaher Revenue in In situ Hybridization Business (2016-2021)
11.7.5 Danaher Recent Development
11.8 Exiqon
11.8.1 Exiqon Company Details
11.8.2 Exiqon Business Overview
11.8.3 Exiqon In situ Hybridization Introduction
11.8.4 Exiqon Revenue in In situ Hybridization Business (2016-2021)
11.8.5 Exiqon Recent Development
11.9 Biogenex Laboratories
11.9.1 Biogenex Laboratories Company Details
11.9.2 Biogenex Laboratories Business Overview
11.9.3 Biogenex Laboratories In situ Hybridization Introduction
11.9.4 Biogenex Laboratories Revenue in In situ Hybridization Business (2016-2021)
11.9.5 Biogenex Laboratories Recent Development
11.10 Advanced Cell Diagnostics
11.10.1 Advanced Cell Diagnostics Company Details
11.10.2 Advanced Cell Diagnostics Business Overview
11.10.3 Advanced Cell Diagnostics In situ Hybridization Introduction
11.10.4 Advanced Cell Diagnostics Revenue in In situ Hybridization Business (2016-2021)
11.10.5 Advanced Cell Diagnostics Recent Development
11.11 Bio Sb
11.11.1 Bio Sb Company Details
11.11.2 Bio Sb Business Overview
11.11.3 Bio Sb In situ Hybridization Introduction
11.11.4 Bio Sb Revenue in In situ Hybridization Business (2016-2021)
11.11.5 Bio Sb Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global In situ Hybridization Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Fluorescence In Situ Hybridization (FISH)
Table 3. Key Players of Chromogenic In Situ Hybridization
Table 4. Global In situ Hybridization Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global In situ Hybridization Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global In situ Hybridization Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global In situ Hybridization Market Share by Regions (2016-2021)
Table 8. Global In situ Hybridization Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global In situ Hybridization Market Share by Regions (2022-2027)
Table 10. In situ Hybridization Market Trends
Table 11. In situ Hybridization Market Drivers
Table 12. In situ Hybridization Market Challenges
Table 13. In situ Hybridization Market Restraints
Table 14. Global In situ Hybridization Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global In situ Hybridization Market Share by Players (2016-2021)
Table 16. Global Top In situ Hybridization Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In situ Hybridization as of 2020)
Table 17. Ranking of Global Top In situ Hybridization Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by In situ Hybridization Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players In situ Hybridization Product Solution and Service
Table 21. Date of Enter into In situ Hybridization Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global In situ Hybridization Market Size by Type (2016-2021) (US$ Million)
Table 24. Global In situ Hybridization Revenue Market Share by Type (2016-2021)
Table 25. Global In situ Hybridization Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global In situ Hybridization Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global In situ Hybridization Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global In situ Hybridization Revenue Market Share by Application (2016-2021)
Table 29. Global In situ Hybridization Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global In situ Hybridization Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America In situ Hybridization Market Size by Type (2016-2021) (US$ Million)
Table 32. North America In situ Hybridization Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America In situ Hybridization Market Size by Application (2016-2021) (US$ Million)
Table 34. North America In situ Hybridization Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America In situ Hybridization Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America In situ Hybridization Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe In situ Hybridization Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe In situ Hybridization Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe In situ Hybridization Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe In situ Hybridization Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe In situ Hybridization Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe In situ Hybridization Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific In situ Hybridization Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific In situ Hybridization Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific In situ Hybridization Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific In situ Hybridization Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific In situ Hybridization Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific In situ Hybridization Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America In situ Hybridization Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America In situ Hybridization Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America In situ Hybridization Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America In situ Hybridization Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America In situ Hybridization Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America In situ Hybridization Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa In situ Hybridization Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa In situ Hybridization Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa In situ Hybridization Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa In situ Hybridization Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa In situ Hybridization Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa In situ Hybridization Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abbott Laboratories Company Details
Table 62. Abbott Laboratories Business Overview
Table 63. Abbott Laboratories In situ Hybridization Product
Table 64. Abbott Laboratories Revenue in In situ Hybridization Business (2016-2021) & (US$ Million)
Table 65. Abbott Laboratories Recent Development
Table 66. Roche Company Details
Table 67. Roche Business Overview
Table 68. Roche In situ Hybridization Product
Table 69. Roche Revenue in In situ Hybridization Business (2016-2021) & (US$ Million)
Table 70. Roche Recent Development
Table 71. Thermo Fisher Scientific Company Details
Table 72. Thermo Fisher Scientific Business Overview
Table 73. Thermo Fisher Scientific In situ Hybridization Product
Table 74. Thermo Fisher Scientific Revenue in In situ Hybridization Business (2016-2021) & (US$ Million)
Table 75. Thermo Fisher Scientific Recent Development
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck In situ Hybridization Product
Table 79. Merck Revenue in In situ Hybridization Business (2016-2021) & (US$ Million)
Table 80. Merck Recent Development
Table 81. Agilent Technologies Company Details
Table 82. Agilent Technologies Business Overview
Table 83. Agilent Technologies In situ Hybridization Product
Table 84. Agilent Technologies Revenue in In situ Hybridization Business (2016-2021) & (US$ Million)
Table 85. Agilent Technologies Recent Development
Table 86. Perkin Elmer Company Details
Table 87. Perkin Elmer Business Overview
Table 88. Perkin Elmer In situ Hybridization Product
Table 89. Perkin Elmer Revenue in In situ Hybridization Business (2016-2021) & (US$ Million)
Table 90. Perkin Elmer Recent Development
Table 91. Danaher Company Details
Table 92. Danaher Business Overview
Table 93. Danaher In situ Hybridization Product
Table 94. Danaher Revenue in In situ Hybridization Business (2016-2021) & (US$ Million)
Table 95. Danaher Recent Development
Table 96. Exiqon Company Details
Table 97. Exiqon Business Overview
Table 98. Exiqon Revenue in In situ Hybridization Business (2016-2021) & (US$ Million)
Table 99. Exiqon Recent Development
Table 100. Biogenex Laboratories Company Details
Table 101. Biogenex Laboratories Business Overview
Table 102. Biogenex Laboratories In situ Hybridization Product
Table 103. Biogenex Laboratories Revenue in In situ Hybridization Business (2016-2021) & (US$ Million)
Table 104. Biogenex Laboratories Recent Development
Table 105. Advanced Cell Diagnostics Company Details
Table 106. Advanced Cell Diagnostics Business Overview
Table 107. Advanced Cell Diagnostics In situ Hybridization Product
Table 108. Advanced Cell Diagnostics Revenue in In situ Hybridization Business (2016-2021) & (US$ Million)
Table 109. Advanced Cell Diagnostics Recent Development
Table 110. Bio Sb Company Details
Table 111. Bio Sb Business Overview
Table 112. Bio Sb In situ Hybridization Product
Table 113. Bio Sb Revenue in In situ Hybridization Business (2016-2021) & (US$ Million)
Table 114. Bio Sb Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In situ Hybridization Market Share by Type: 2020 VS 2027
Figure 2. Fluorescence In Situ Hybridization (FISH) Features
Figure 3. Chromogenic In Situ Hybridization Features
Figure 4. Global In situ Hybridization Market Share by Application: 2020 VS 2027
Figure 5. Cancer Diagnosis Case Studies
Figure 6. Immunology Case Studies
Figure 7. Neuroscience Case Studies
Figure 8. Cytology Case Studies
Figure 9. Infectious Diseases Case Studies
Figure 10. In situ Hybridization Report Years Considered
Figure 11. Global In situ Hybridization Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global In situ Hybridization Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global In situ Hybridization Market Share by Regions: 2020 VS 2027
Figure 14. Global In situ Hybridization Market Share by Regions (2022-2027)
Figure 15. Global In situ Hybridization Market Share by Players in 2020
Figure 16. Global Top In situ Hybridization Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In situ Hybridization as of 2020
Figure 17. The Top 10 and 5 Players Market Share by In situ Hybridization Revenue in 2020
Figure 18. Global In situ Hybridization Revenue Market Share by Type (2016-2021)
Figure 19. Global In situ Hybridization Revenue Market Share by Type (2022-2027)
Figure 20. North America In situ Hybridization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America In situ Hybridization Market Share by Type (2016-2027)
Figure 22. North America In situ Hybridization Market Share by Application (2016-2027)
Figure 23. North America In situ Hybridization Market Share by Country (2016-2027)
Figure 24. United States In situ Hybridization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada In situ Hybridization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe In situ Hybridization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe In situ Hybridization Market Share by Type (2016-2027)
Figure 28. Europe In situ Hybridization Market Share by Application (2016-2027)
Figure 29. Europe In situ Hybridization Market Share by Country (2016-2027)
Figure 30. Germany In situ Hybridization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France In situ Hybridization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. In situ Hybridization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy In situ Hybridization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia In situ Hybridization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic In situ Hybridization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific In situ Hybridization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific In situ Hybridization Market Share by Type (2016-2027)
Figure 38. Asia-Pacific In situ Hybridization Market Share by Application (2016-2027)
Figure 39. Asia-Pacific In situ Hybridization Market Share by Region (2016-2027)
Figure 40. China In situ Hybridization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan In situ Hybridization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea In situ Hybridization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia In situ Hybridization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India In situ Hybridization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia In situ Hybridization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America In situ Hybridization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America In situ Hybridization Market Share by Type (2016-2027)
Figure 48. Latin America In situ Hybridization Market Share by Application (2016-2027)
Figure 49. Latin America In situ Hybridization Market Share by Country (2016-2027)
Figure 50. Mexico In situ Hybridization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil In situ Hybridization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa In situ Hybridization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa In situ Hybridization Market Share by Type (2016-2027)
Figure 54. Middle East & Africa In situ Hybridization Market Share by Application (2016-2027)
Figure 55. Middle East & Africa In situ Hybridization Market Share by Country (2016-2027)
Figure 56. Turkey In situ Hybridization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia In situ Hybridization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE In situ Hybridization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Abbott Laboratories Revenue Growth Rate in In situ Hybridization Business (2016-2021)
Figure 60. Roche Revenue Growth Rate in In situ Hybridization Business (2016-2021)
Figure 61. Thermo Fisher Scientific Revenue Growth Rate in In situ Hybridization Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in In situ Hybridization Business (2016-2021)
Figure 63. Agilent Technologies Revenue Growth Rate in In situ Hybridization Business (2016-2021)
Figure 64. Perkin Elmer Revenue Growth Rate in In situ Hybridization Business (2016-2021)
Figure 65. Danaher Revenue Growth Rate in In situ Hybridization Business (2016-2021)
Figure 66. Exiqon Revenue Growth Rate in In situ Hybridization Business (2016-2021)
Figure 67. Biogenex Laboratories Revenue Growth Rate in In situ Hybridization Business (2016-2021)
Figure 68. Advanced Cell Diagnostics Revenue Growth Rate in In situ Hybridization Business (2016-2021)
Figure 69. Bio Sb Revenue Growth Rate in In situ Hybridization Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed